PBC-ers who want to stay informed with new articles about the promising Bezafibrate, please check:
link.springer.com/article/1...
(Journal of Gastroenterology)
PBC-ers who want to stay informed with new articles about the promising Bezafibrate, please check:
link.springer.com/article/1...
(Journal of Gastroenterology)
thank you for the share
Interesting that they added nothing about the hepatoxicity risks, also published at AASLD 2019.
You are right, they only said:
"The authors concluded that advanced cirrhosis and severe cholestasis could limit therapy with bezafibrate..."
But in the package insert it is listed.
Take care and stay healthy in these days.